Morningstar6d
LINDIS BIOTECH AND PHARMANOVIA ANNOUNCE EUROPEAN MARKETING AUTHORISATION APPROVAL FOR CATUMAXOMAB, A FIRST-IN-CLASS TREATMENT FOR MALIGNANT ASCITES
Dr. Horst Lindhofer, Chief Executive Officer of Lindis Biotech, added: "We are delighted to receive marketing approval for catumaxomab. The approval highlights its potential to address the ...
PharmiWeb6d
Lindis Biotech and Pharmanovia Announce European Marketing Authorization Approval for Catumaxomab, A First-In-Class Treatment for Malignant Ascites
Dr. Horst Lindhofer, Chief Executive Officer of Lindis Biotech, added: "We are delighted to receive marketing approval for catumaxomab. The approval highlights its potential to address the significant ...
Indiatimes1d
India News
A Class X student in Gujarat, who was raped by her teacher following her Beti Bachao, Beti Padhao speech, is displaying remarkable resilience by focusing on her upcoming board exams and her dream ...